Do you want to read an article? Please log in or register.
Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic
Uveitis
Related content
UveitisFurther Publications
The association between non-infectious uveitis and COVID-19 outcomes: an analysis of United States claims-based data
Ophthalmology
Miller DC, Sun Y, Chen EM, Arnold BF, Acharya NR
doi: 10.1016/j.ophtha.2021.10.007
Uveitis
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative
Ophthalmology.
Dick AD, Rosenbaum JT, Al-Dhibi HA, Belfort R Jr., Brézin AP, Chee SP, Davis JL, Ramanan AV, Sonoda KH, Carreño E, Nascimento H, Salah S, Salek S, Siak J, Steeples L; Fundamentals of Care for Uveitis International Consensus Group
doi: 10.1016/j.ophtha.2017.11.017.
Uveitis
Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis
Cochrane Database Syst Rev.
Barry RJ, Tallouzi MO, Bucknall N, Mathers JM, Murray PI, Calvert MJ, Moore DJ, Denniston AK
doi: 10.1002/14651858.
RECOMMENDED
Uveitis
Risk of Non-infectious Uveitis with Female Hormonal Therapy in a Large Healthcare Claims Database
★ 2
Recommended by
Prof. Dr emer. Josef Flammer, Faculty Member
doi: 10.1016/j.ophtha.2020.04.034.
Glaucoma and Ocular Pressure
Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19
JAMA Ophthalmol.
Bommakanti NK, Zhou Y, Ehrlich JR, Elam AR, John D, Kamat SS, Kelstrom J, Newman-Casey PA, Shah MM, Weizer JS, Wood SD, Zhang AD, Zhang J, Lee PP, Stein JD, SOURCE Consortium
doi: 10.1001/jamaophthalmol.
Retinal DiseasesSurgery and InterventionFurther Publications
Frequency of Urgent or Emergent Vitreoretinal Surgical Procedures in the United States During the COVID-19 Pandemic
JAMA Ophthalmol
Breazzano MP, Nair AA, Arevalo JF, Barakat MR, Berrocal AM, Chang JS, Chen A, Eliott D, Garg SJ, Ghadiali Q, Gong D, Grewal DS, Handa JT, Henderson M, Leiderman YI, Leng T, Mannina A, Mendel TA, Mustafi D, de Koo LCO, Patel SN, Patel TP, Prenner J, Richards P, Singh RP, Wykoff CC, Yannuzzi NA, Yu H, Modi YS, Chang S
doi: 10.1001/jamaophthalmol.2021.0036
RECOMMENDED
Uveitis
Collaborative Ocular Tuberculosis Study (COTS) Consensus Guidelines on the Management of Tubercular Uveitis - Report 2: Guidelines for Initiating Anti-Tubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis and Retinal Vasculitis
★ 3
Recommended by
Prof. Dr Ke Yao, Faculty Member
Ophthalmology.
Agrawal R, Testi I, Bodaghi B, Barisani-Asenbauer T, McCluskey P, Agarwal A, Kempen JH, Gupta A, Smith JR, de Smet MD, Yuen YS, Mahajan S, Kon OM, Nguyen QD, Pavesio C, Gupta V, for COTS CON group.
doi: 10.1016/j.ophtha.2020.06.052.
Retinal DiseasesSurgery and InterventionFurther Publications
The impact of the COVID-19 Pandemic on rhegmatogenous retinal detachment treatment patterns
BMC Ophthalmol
Li J, Zhao M, She H
doi: 10.1186/s12886-021-02127-7
Uveitis
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis
Ophthalmology.
Agrawal R, Testi I, Mahajan S, Yuen YS, Agarwal A, Kon OM, Barisani-Asenbauer T, Kempen JH, Gupta A, Jabs DA, Smith JR, Nguyen QD, Pavesio C, Gupta V, Collaborative Ocular Tuberculosis Study Consensus Group.
doi: 10.1016/j.ophtha.2020.01.008.